SCHEMBL25826458

SCHEMBL25826458

Bc1cc([C@]2(C#N)OC(C(B)(B)OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)[C@H]2OC(=O)C(C)C)n2ncnc(/N=C\N(C)C)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25826245 0.89 — —
SCHEMBL25826433 0.89 TMPRSS2 (0.30) —
SCHEMBL25827017 0.86 PIK3CD (0.30) —
SCHEMBL25826406 0.86 — —
SCHEMBL25825896 0.78 TMPRSS2 (0.37) —
SCHEMBL25825714 0.77 TMPRSS2 (0.35) —
SCHEMBL25826978 0.76 TMPRSS2 (0.33) —
SCHEMBL25826990 0.74 PIK3CD (0.32) —
SCHEMBL25822042 0.74 TMPRSS2 (0.40) —
SCHEMBL23960059 0.73 TMPRSS2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219993-A1 ANTIVIRAL APPLICATION OF NUCLEOSIDE ANALOG OR COMBINATION FORMULATION CONTAINING NUCLEOSIDE ANALOG VIGONVITA LIFE SCIENCES CO., LTD. (CN) 2023-07-13 — — US disclosed
Send feedback